ReviewFrontiers in pharmacology2021

Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries.

Alessandra Blonda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.